Streptococcus suis type 2 10-gene-deleted strain and application
A technology of Streptococcus suis, gene deletion, applied in bacteria, antibacterial drugs, veterinary vaccines, etc., can solve the problem of ineffective activation of the mucosal immune system, and achieve the effect of avoiding immunogenic damage, decreased virulence, and genetic stability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0059] The acquisition of Streptococcus suis 10 gene deletion strain LSM110D10:
[0060] According to the complete genome GB|CP000407.1| of Streptococcus suis type 2 05ZYH33 strain published on GenBank, primers were designed to amplify the upstream homology arm and downstream homology arm of the gene to be deleted from the SC genome of Streptococcus suis type 2 wild strain, Construct a knockout vector for knockout of the target gene. The applicant constructs and screens the deletion strain by using a reverse selection marker through a two-step single-exchange homologous recombination method between the recombinant plasmid and the strain genome. This method can be used repeatedly to construct polygenic mutants without leaving any selection markers, see the related report of Dr. Daisuke Takamatsu (Daisuke Tetal, 2001, 45:101-113).
[0061] After the target gene is knocked out, design a pair of primers located on both sides of the gene and a pair of primers located inside the ge...
Embodiment 2
[0069] Characteristics of Streptococcus suis 10 gene deletion strain LSM110D10:
[0070] 1) Observing under the electron microscope the virulent strain SC of Streptococcus suis type 2 and the 10 gene deletion strain of Streptococcus suis LSM110D10, both of them formed normal bacterial morphology, cell wall and capsule, and there was no significant difference in the morphology of the two, Figure 6.
[0071] 2) Determination of drug resistance. The virulent strain SC of Streptococcus suis type 2 and the 10 gene deletion strain of Streptococcus suis LSM110D10 were respectively inoculated in 5 mL of TSB medium containing 10% newborn bovine serum, cultured to logarithmic phase at 37°C, and the concentration was adjusted to 1.2× 10 9 CFU / mL, take 100μL and evenly spread it on the MH+10% sheep blood plate, paste the penicillin E-test strip, carefully drive out the air bubbles, and take a reading after incubation at 37°C for 24 hours. The result is as follows: Figure 7 , Figure...
Embodiment 3
[0076] The safety of Streptococcus suis 10 gene deletion strain LSM110D10:
[0077] 1) Determination of hemolytic activity. The strain was inoculated in 5 mL of TSB medium containing 10% newborn bovine serum and cultivated to the logarithmic phase, and the concentration was adjusted to 5×10 7 CFU / mL, add 100 μL to 900 μL 5% fresh sheep red blood cells, add 100 μL PBS buffer to the negative control group, incubate at 37°C for 2 hours, centrifuge to get the supernatant, measure the absorbance at 570nm, the results are as follows Figure 9 , Figure 9 It is the hemolytic activity determination result of LSM110D10 of the present invention and the virulent strain SC of Streptococcus suis type 2, and a 3-deletion mutant strain without knocking out the hemolysin gene Sly is used as a control, obtained by Figure 9 It can be seen that the OD value of SC and 3 deletion can reach about 0.9, while the OD values of LSM110D10 and the blank control group are both about 0.1, indicating t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com